Bentley Gets Approval to Market Generic Versions of Risperidone in Spain

Bentley Pharmaceuticals has announced that one of its Spanish subsidiaries, Laboratorios Davur, has received approval to market 1-, 3- and 6-mg generic dosage versions of risperidone in Spain.

Risperidone belongs to a class of antipsychotic products used in the treatment of schizophrenia. The product is marketed by Janssen Pharmaceutica Products, L.P. in the U.S. under the trade name Risperdal.

According to IMS, the market size of antipsychotic pharmaceutical products in Spain is approximately $415 million, of which, risperidone accounts for approximately $100 million.